In patients with suspected ovarian cancer, the use of expert gynecologic ultrasonographers, compared with nonspecialists, improves diagnostic accuracy and reduces the number of major surgical staging procedures required to confirm or rule out a diagnosis of cancer, reports an article published online Jan. 21 in The Lancet.
In patients with suspected ovarian cancer, the use of expert gynecologic ultrasonographers, compared with nonspecialists, improves diagnostic accuracy and reduces the number of major surgical staging procedures required to confirm or rule out a diagnosis of cancer, reports an article published online Jan. 21 in The Lancet.
British researchers randomly assigned 150 patients with suspected adnexal tumors to level II (routine) ultrasonography or level III (expert) ultrasonography and then compared the number of surgical procedures performed in each group.
More major surgical staging procedures were performed in the level II group-27 of 73 (37%) than in the level III group-17 of 77 (22%)-although the total number of surgical procedures was similar between groups. Ultrasound results provided clinicians with a likely histological diagnosis in 76 of 77 (99%) of the level III patients but in only 38 of 73 (52%) of the level II group.
"This finding is likely to be the consequence of the greatly increased proportion of patients in whom a conclusive diagnosis of the nature of the adnexal tumour was possible from level III ultrasonography compared with level II ultrasonography," conclude the authors.
Yazbek J, Raju SK, Ben-Nagi J, et al. Effect of quality of gynaecological ultrasonography on management of patients with suspected ovarian cancer: a randomised controlled trial. Lancet Oncol. 2008;9:124-131. doi:10.1016/S1470-2045(08)70005-6.
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More